Precision Business Insights
Portfolio

 

Inhalers Market

: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2018-2023

Global Inhalers Market: By Device Type [Metered Dose Inhaler, Dry Powder Inhaler, Nebulizer (Compressed, Ultrasonic, Mesh)], By Inhaler Type (Preventive, Reliever, Long Acting Bronchodilators), By Application(  Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Cystic Fibrosis), By End User (  Home Care, Hospitals, Clinics), and Geography 

 

Inhalers Market Size and Overview:

 

The global inhalers market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2018-2023 due to technological progressions in the inhalers and rising governments alertness. Moreover, accumulative number of smokers and growing frequency of pulmonary diseases are the major factors driving the growth of the market. Furthermore, increasing pollution across the world, leads to increase in respiratory problems, which propels the growth of the market over the forecast years.

 

Global Inhalers Market Report Description:

Global inhalers market report gives comprehensive outlook on inhalers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global inhalers market gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, inhaler type, end user, and region. This report studies the dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global  market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global inhalers market report include suppliers, manufacturers, and marketers, policy makers engaged in global inhalers products.

 

Increasing Prevalence of Pulmonary Diseases Enhances the Market Growth of Global Inhalers

Growing pollution through the world, leads to upsurge in respiratory problems, which boosts the growth of the market over the coming years. COPD, asthma, acute lower respiratory tract infections, TB and lung cancer are amongst most communal causes of severe illness and death globally. For example, according WHO, in 2016, around 65 million people have moderate to severe chronic obstructive pulmonary disease (COPD), from which about 3 million die each year, making it the third leading cause of death worldwide.

 

North America Accounts for Larger Market Revenue Share in Global Inhalers Market

North America accounted for larger revenue share in global Inhalers market with significant CAGR owing to increase in prevalence of chronic obstructive pulmonary disease (COPD) over there, increase in research and development for developing new treatment therapies, and improved healthcare facilities. Europe inhalers market accounted for a significant share in global inhalers market. The usage of metered dose inhalers is more popular in European countries leading to the growth of the segment in the region. Asia Pacific inhalers market expected to grow significantly rate due to their emerging economies, increase in the prevalence of COPD, development of healthcare infrastructure, and technological advancements.

 

Competition Assessment

Key player’s profiles in the global inhalers market include:

  • 3M Company (USA)
  • Aradigm Corporation (California)
  • AstraZeneca Plc. (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • Cipla Inc. (India)
  • GlaxoSmithKline (UK)
  • Novartis AG (Switzerland)
  • PULMATRIX, INC. (USA)
  • Teva Respiratory, LLC. (USA)
  • Mankind Corporation (Califonia)
  • BESPAK (UK)
  • Beximo Pharmaceuticals Limited (Bangladesh)
  • Spyryx Biosciences, Inc. (North Carolina)
  • MidasCare Pharmaceuticals Pvt. Ltd. (India)
  • Omega Life Sciences Ltd. (Isreal)
  • Drive DeVilbiss Healthcare Ltd. (UK)
  • Manta Devices LLC. (Cambridge)
  • Savara Inc. (USA)
  • OMRON Healthcare Europe B.V. (Europe)
  • Hovione LLC. (USA)
  • Koninklijke Philips N.V. (Netherlands)
  • Teijin Limited (Japan)
  • Vitalograph Ltd. (UK)

 

Global inhalers market is surging owing to frequent acquisitions, product launch, and collaborations by the market players.

  • For instance, in 2018, the company 3M has introduced an enhanced version of one rescue inhaler in the market.

 

Detailed Segmentation

 

By Device Type

  • Metered Dose Inhaler
  • Dry Powder Inhaler
  • Nebulizer
    • Compressed
    • Ultrasonic
    • Mesh

 

By Inhaler Type

  • Preventive
  • Reliever
  • Long Acting Bronchodilators

 

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Cystic Fibrosis

 

End Users

  • Home Care
  • Hospitals
  • Clinics

 

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Findings of the Report:

 

  • Global inhalers market expanding at significant CAGR over 2018 to 2023 owing to launch of newer products into market.
  • Based on device type, metered dose inhaler segment accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global Inhalers market

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market and forecast (2018-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Table of Content

  1. Executive Summary
  2. Global Inhalers Market Introduction
    • Global Inhalers Market – Taxonomy
    • Global Inhalers Market –Definitions
      • By DeviceType
      • By Inhaler Type
      • By Application
      • By End User
  1. Global Inhalers Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Inhalers Market Dynamic Factors – Impact Analysis
    • Global Inhalers Market – Competition Landscape
  2. Global Inhalers Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023
    • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Inhalers Market, By Device Type, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Metered Dose Inhaler
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dry Powder Inhaler
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Nebulizer
      • Compressed
        • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Ultrasonic
        • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Mesh
        • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Inhalers Market, By Inhaler Type, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Preventive
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Reliever
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Long Acting Bronchodilators
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Inhalers Market, By Application, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Asthma
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Chronic Obstructive Pulmonary Disease
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pulmonary Arterial Hypertension
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cystic Fibrosis
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Inhalers Market, By End User, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Home Care
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hospitals
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Inhalers Market Forecast, By Region, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Inhalers Market – Opportunity Analysis Index, By Device Type, Inhaler Type, By Application, By End User, and Region, 2018 – 2023
  2. North America Inhalers Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Device Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Metered Dose Inhaler
      • Dry Powder Inhaler
      • Nebulizer
        • Compressed
        • Ultrasonic
        • Mesh
      • Inhaler Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Preventive
        • Reliever
        • Long Acting Bronchodilators
      • By Application Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Asthma
        • Chronic Obstructive Pulmonary Disease
        • Pulmonary Arterial Hypertension
        • Cystic Fibrosis
      • By End User Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Home Care
        • Hospitals
        • Clinics
      • Country Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • USA
        • Canada
      • North America Inhalers Market – Opportunity Analysis Index, By Device Type, Inhaler Type, By Application, By End User, and Country, 2018 – 2023
      • North America Inhalers Market Dynamics – Trends
  1. Europe Inhalers Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Device Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Metered Dose Inhaler
      • Dry Powder Inhaler
      • Nebulizer
        • Compressed
        • Ultrasonic
        • Mesh
      • Inhaler Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Preventive
        • Reliever
        • Long Acting Bronchodilators
      • By Application Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Asthma
        • Chronic Obstructive Pulmonary Disease
        • Pulmonary Arterial Hypertension
        • Cystic Fibrosis
      • By End User Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Home Care
        • Hospitals
        • Clinics
      • Country Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Inhalers Market – By Device Type, Inhaler Type, By Application, By End User, and Country, 2018 – 2023
      • Europe Inhalers Market Dynamics – Trends
  1. Asia Pacific Inhalers Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Device Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Metered Dose Inhaler
      • Dry Powder Inhaler
      • Nebulizer
        • Compressed
        • Ultrasonic
        • Mesh
      • Inhaler Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Preventive
        • Reliever
        • Long Acting Bronchodilators
      • By Application Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Asthma
        • Chronic Obstructive Pulmonary Disease
        • Pulmonary Arterial Hypertension
        • Cystic Fibrosis
      • By End User Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Home Care
        • Hospitals
        • Clinics
      • Country Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Inhalers Market – Opportunity Analysis Index, By Device Type, Inhaler Type, By Application, By End User, and Country, 2018 – 2023
      • Asia-Pacific Inhalers Market Dynamics – Trends
  1. Latin America Inhalers Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Device Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Metered Dose Inhaler
      • Dry Powder Inhaler
      • Nebulizer
        • Compressed
        • Ultrasonic
        • Mesh
      • Inhaler Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Preventive
        • Reliever
        • Long Acting Bronchodilators
      • By Application Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Asthma
        • Chronic Obstructive Pulmonary Disease
        • Pulmonary Arterial Hypertension
        • Cystic Fibrosis
      • By End User Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Home Care
        • Hospitals
        • Clinics
      • Country Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • Latin America Inhalers Market – Opportunity Analysis Index, By Device Type, Inhaler Type, By Application, By End User, and Country, 2018 – 2023
      • Latin America Inhalers Market Dynamics – Trends
  1. Middle East and Africa Inhalers Market Analysis, 2014 – 2018 and Forecast, 2018 – 2023 (Revenue, USD Mn)
    • Device Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Metered Dose Inhaler
      • Dry Powder Inhaler
      • Nebulizer
        • Compressed
        • Ultrasonic
        • Mesh
      • Inhaler Type Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Preventive
        • Reliever
        • Long Acting Bronchodilators
      • By Application Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Asthma
        • Chronic Obstructive Pulmonary Disease
        • Pulmonary Arterial Hypertension
        • Cystic Fibrosis
      • By End User Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Home Care
        • Hospitals
        • Clinics
      • Country Analysis 2014 – 2018 and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Inhalers Market – Opportunity Analysis Index, By Device Type, Inhaler Type, By Application, By End User, and Country, 2018 – 2023
      • MEA Inhalers Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • 3M Company (USA)
      • Aradigm Corporation (California)
      • AstraZeneca Plc. (UK)
      • Boehringer Ingelheim GmbH (Germany)
      • Cipla Inc. (India)
      • GlaxoSmithKline (UK)
      • Novartis AG (Switzerland)
      • PULMATRIX, INC. (USA)
      • Teva Respiratory, LLC. (USA)
      • Mankind Corporation (Califonia)
      • BESPAK (UK)
      • Beximo Pharmaceuticals Limited (Bangladesh)
      • Spyryx Biosciences, Inc. (North Carolina)
      • MidasCare Pharmaceuticals Pvt. Ltd. (India)
      • Omega Life Sciences Ltd. (Isreal)
      • Drive DeVilbiss Healthcare Ltd. (UK)
      • Manta Devices LLC. (Cambridge)
      • Savara Inc. (USA)
      • OMRON Healthcare Europe B.V. (Europe)
      • Hovione LLC. (USA)
      • Koninklijke Philips N.V. (Netherlands)
      • Teijin Limited (Japan)
      • Vitalograph Ltd. (UK)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials